SANOFICONR — Sanofi Consumer Healthcare India Cashflow Statement
0.000.00%
- IN₹107.87bn
- IN₹105.97bn
- IN₹7.25bn
Annual cashflow statement for Sanofi Consumer Healthcare India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Net Income/Starting Line | 2,193 | 2,468 |
| Depreciation | ||
| Non-Cash Items | -40 | -40 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -2,175 | 1,917 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -4 | 4,390 |
| Capital Expenditures | -40 | -99 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 40 | 118 |
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 0 | 19 |
| Financing Cash Flow Items | 0 | -4 |
| Other Financing Cash Flow | ||
| Total Cash Dividends Paid | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 20 | -1,156 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 16 | 3,253 |